Approval · Notice of Compliance 22884 · 2019
KAMRAB: Notice of Compliance 22884
Issued November 8, 2019
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 22884
- Date
- November 8, 2019
- Company
- Kamada LtdKiryat Weizmann Science Park, Rehovot, Israel
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Labelling Only
- Reason
- Labelling updates
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| KAMRAB | Not yet assigned | — |
Medicinal ingredients
- RABIES IMMUNOGLOBULIN, HUMAN 2 ML per VIAL
- RABIES IMMUNOGLOBULIN, HUMAN 10 ML per VIAL